Literature DB >> 22841337

Marketing versus evidence-based medicine.

Alain Braillon, Susan Bewley, Andrew Herxheimer, Peter Mansfield, Joel Lexchin, David B Menkes, Liliya E Ziganshina, Jean-Louis Montastruc.   

Abstract

Mesh：

Year:  2012        PMID： 22841337     DOI： 10.1016/S0140-6736(12)61250-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

Review 2.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

3.  Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.

Authors:  Ali T Taher; John B Porter; Antonis Kattamis; Vip Viprakasit; M Domenica Cappellini
Journal:  Drug Des Devel Ther       Date:  2016-12-15       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.